Monthly Archives: June 2025
New Biosimilars of Xolair and Actemra Now Available: Omlyclo and Tyenne
Biosimilars are becoming more common in Canada, offering patients trusted alternatives to the originator biologic medication. Biosimilars are not the same as generics. Generics are exact chemical copies of brand-name drugs, like acetaminophen for Tylenol. Biosimilars are made from living cells and … Continue reading
NACI Releases Official Statement on Shingrix Vaccination in Immunocompromised Individuals
If you have a weakened immune system due to a condition (for example, rheumatoid arthritis) or due to a treatment (for example, chemotherapy), you may be at higher risk of developing shingles (herpes zoster). Shingles can have serious complications such … Continue reading